DESCRIBE <http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91	http://www.w3.org/2000/01/rdf-schema#comment	"Data suggest that antinociceptive agent SBFI-26 binds at a portal site as well as at the canonical site in the substrate pocket of FABP5 and FABP7; only the S form of SBFI-26 binds to both FABP5 and FABP7 in their co-crystal structures; SBFI-26 induces conformational changes in FABP5 and FABP7."xsd:string
http://purl.uniprot.org/uniprot/#_46513F641A0E9A0D6117AB25A5DDE33E1063D3AB32136DC7C217D695264F0C36082B8FB1B1BAAE657E34B835F4EF275F	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91
http://purl.uniprot.org/uniprot/A0A077H155	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91
http://purl.uniprot.org/uniprot/#_A0A077H155-mappedCitation-28632393	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/ED56E6983BBC0A1C8728D81D8962671E394A42B159B1143CD7397A472FFEBBE852F12CFE9CD25BE2AC447730F7C39F91